Benzinga | Jul 15, 2021 07:29AM EDT

Sana Biotech To Establish Manufacturing Facility For Gene, Cell Therapy Candidates

* Sana Biotechnology Inc (NASDAQ:SANA) has entered into a lease agreement to develop a 163,000 square foot manufacturing facility in Fremont, California.

* The facility will support the manufacture of Sana's late-stage clinical development and early commercial product candidates.

* The facility will be designed to provide manufacturing capabilities across Sana's portfolio, including allogeneic T cell, viral vector, and pluripotent stem cell production.

* The Company also plans to work with contract manufacturing partners to advance its product candidates to the clinic as early as next year.

* Price Action: SANA shares closed at $17.42 on Wednesday.